Gilpin Wealth Management’s Skye Bioscience SKYE Stock Holding History

Gilpin Wealth Management’s Portfolio SKYE Stock Details SKYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-1	Closed	-$3	–	1484
2026 Q2	$3	Buy	+1	New	+$6	﹤0.01%	1064

Gilpin Wealth Management's SKYE Position: Q3 2026 in Review

Gilpin Wealth Management sold out of Skye Bioscience (SKYE) in Q3 2026, closing a stake of 1 share — an estimated $3 sold.

Gilpin Wealth Management first reported a position in SKYE in Q2 2026 and held it in 1 quarter. The position peaked at $3 in Q2 2026. 0 funds tracked by Wall St. Rank hold SKYE as of Q3 2026.

Gilpin Wealth Management reported no remaining Skye Bioscience position as of Q3 2026 after selling out during the quarter.
Gilpin Wealth Management sold 1 Skye Bioscience share in Q3 2026, an estimated $3.
Gilpin Wealth Management first reported a position in Skye Bioscience in Q2 2026 and held it in 1 quarter.
Gilpin Wealth Management's Skye Bioscience position peaked at $3 in Q2 2026.
0 funds tracked by Wall St. Rank held Skye Bioscience as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.